On Friday, June 15, 2012, the Board of Dentistry voted to adopt Board Rule 150-14-.04 entitled “Administration of Injectable Pharmacologics”. The new Board Rule will become effective on July 9, 2012. The new Board Rule should be carefully reviewed by all dentists who wish to utilize injectable pharmacologics, including hyaluronic acid (such as Restylane), fillers (such as collagen), Botulinum Toxin Type A (such as Botox), or similar products approved by the Federal Food and Drug Administration. The Rule provides that dentists may administer an injectable pharmacologic only after having completed a Board-approved post-doctoral course. However, a dentist who has successfully completed an ADA accredited oral and maxillofacial surgery advanced specialty education program shall not be required to complete the Board-approved course. The Rule also provides that use of injectable pharmacologics without having first met the Rule’s requirements for training shall constitute a deviation from the acceptable standards of practice and may subject a dentist to disciplinary action.